Inventor · disambiguated record
Thomas C. Malone
Also filed as: MALONE THOMAS · MALONE THOMAS C · MALONE THOMAS CHARLES
80 granted patents·11 pending applications·916 citations·filing 1987–2021
99Inventor score
Top patents by PatentIndex Score
91 records- 0198US8512738B2Biodegradable intravitreal tyrosine kinase implantsEDELMAN JEFFREY L·Filed 2005·Granted Aug 20, 2013·89 cites·6 claims
- 0297US8409607B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Apr 2, 2013·81 cites·8 claims
- 0397US6765012B23-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2002·Granted Jul 20, 2004·137 cites·20 claims
- 0496US6747025B1Kinase inhibitors for the treatment of diseaseALLERGAN INC·Filed 2003·Granted Jun 8, 2004·57 cites·9 claims
- 0594US8968766B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2013·Granted Mar 3, 2015·19 cites·8 claims
- 0694US7771742B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2004·Granted Aug 10, 2010·47 cites·15 claims
- 0793US6541504B1(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN SALES LLC·Filed 2002·Granted Apr 1, 2003·61 cites·18 claims
- 0892US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 0992US7767718B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Aug 3, 2010·7 cites·50 claims
- 1092US7015220B23-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2004·Granted Mar 21, 2006·37 cites·45 claims
- 1192US6458781B1Substituted diarylalkyl amides as calcium channel antagonistsFiled 1999·Granted Oct 1, 2002·68 cites·20 claims
- 1290US7125908B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Oct 24, 2006·21 cites·51 claims
- 1389US7705055B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Apr 27, 2010·4 cites·46 claims
- 1488US9233968B1Kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jan 12, 2016·5 cites·6 claims
- 1588US7060723B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2004·Granted Jun 13, 2006·18 cites·47 claims
- 1688US7060844B2(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2003·Granted Jun 13, 2006·29 cites·3 claims
- 1788US5145845ASubstituted 2-carboxylindoles having pharmaceutical activityWARNER LAMBERT CO·Filed 1991·Granted Sep 8, 1992·39 cites·16 claims
- 1887US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 1987US9371314B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jun 21, 2016·3 cites·18 claims
- 2087US7763651B2Treating pain using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Jul 27, 2010·3 cites·50 claims
- 2186US5002950A7-deazaguanines as immunomodulatorsWARNER LAMBERT CO·Filed 1990·Granted Mar 26, 1991·30 cites·6 claims
- 2285US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 2385US8906892B24-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2012·Granted Dec 9, 2014·5 cites·15 claims
- 2485US8153645B2Treating pain using selective antagonists of persistent sodium currentEHRING GEORGE R·Filed 2006·Granted Apr 10, 2012·3 cites·36 claims
- 2582US9433631B24-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2014·Granted Sep 6, 2016·3 cites·12 claims
- 2682US8367664B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Feb 5, 2013·3 cites·11 claims
- 2781US7749530B2Kinase inhibitorsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·5 cites·31 claims
- 2880US7915443B2Sulfoximines as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Mar 29, 2011·5 cites·44 claims
- 2979US8404267B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Mar 26, 2013·2 cites·3 claims
- 3079US7977351B2Heteroaryl dihydroindolones as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Jul 12, 2011·3 cites·19 claims
- 3178US8877923B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Nov 4, 2014·2 cites·3 claims
- 3278US6197771B1Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinedionesWARNER LAMBERT CO·Filed 2000·Granted Mar 6, 2001·9 cites·6 claims
- 3378US4921858A7-deazaguanines as immunomodulatorsWARNER LAMBERT CO·Filed 1987·Granted May 1, 1990·12 cites·8 claims
- 3477US9359336B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jun 7, 2016·1 cites·8 claims
- 3576US8455656B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Jun 4, 2013·2 cites·2 claims
- 3675US9255096B1Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Feb 9, 2016·1 cites·10 claims
- 3775US6423689B1Peptidyl calcium channel blockersWARNER LAMBERT CO·Filed 1998·Granted Jul 23, 2002·48 cites·146 claims
- 3874US8865682B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Oct 21, 2014·1 cites·4 claims
- 3974US8455535B2Heteroaryl dihydroindolones as kinase inhibitorsBORAL SOUGATO·Filed 2011·Granted Jun 4, 2013·3 cites·21 claims
- 4074US8338415B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsGUO XIALING·Filed 2007·Granted Dec 25, 2012·1 cites·6 claims
- 4173US8143410B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Mar 27, 2012·1 cites·28 claims
- 4273US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 4373US2021115029A1Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2020·Application pending·0 cites
- 4469US9266869B2Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Feb 23, 2016·1 cites·18 claims
- 4568US10633373B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Apr 28, 2020·0 cites·2 claims
- 4667US9657005B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Granted May 23, 2017·0 cites·1 claims
- 4767US7728034B2Treating neurological disorders using selective antagonists of persistent sodium currentALLERGAN INC·Filed 2006·Granted Jun 1, 2010·0 cites·46 claims
- 4867US7294716B2Process for preparing isomerically pure prodrugs of proton pump inhibitorsALLERGAN INC·Filed 2004·Granted Nov 13, 2007·4 cites·29 claims
- 4966US10669265B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Jun 2, 2020·0 cites·1 claims
- 5066US9758509B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Sep 12, 2017·0 cites·1 claims
Showing the top 50 of 91 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas C. Malone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →